It is the aim of this paper to review and integrate relevant empirical findings and theoretical discussions concerning the molecular and cellular mechanisms and effects of MDMA-induced 5-HT neurotoxicity in laboratory animals. 3,4-methylenedioxymethamphetamine (MDMA) is a derivative of the synthetic psychostimulant methamphetamine (METH). It also shares some structural and pharmacological properties of mescaline, a naturally occurring psychedelic hallucinogen. At the molecular level, all three substances resemble the monoamine neurotransmitters epinephrine (E) and dopamine (DA). They mimic the neurophysiological actions and effects of E and DA, as well as serotonin (5-HT). METH and MDMA do so by binding to, and reversal of monoamine-specific transporter proteins at the presynaptic plasma membrane. While the psychological effects of METH are mainly due its action as a DA release agent and reuptake inhibitor, MDMA primarily affects the serotonergic system. It has a high affinity for the serotonin-specific transporter (SERT), which carries it into the presynaptic neuron. Inside the cell, MDMA inhibits the vesicular monoamine transporter type 2 (VMAT2), pre-venting intracellular 5-HT from being stored in synaptic vesicles. In addition, MDMA phos-phorylates SERT, which causes a reversal of its reuptake function and, hence, non-exocytotic efflux of 5-HT by the means of passive diffusion. Because neurotransmitter release normally only occurs in case of an action potential, and the released transmitter is partly reabsorbed and recycled, the reverse functioning of SERT depletes 5-HT stores. The equivalent effect of METH via reversal of the DA transporter (DAT) has been linked to its neurotoxic properties (Yamamoto & Zhu, 1998). As a derivative of methamphetamine, MDMA is sometimes believed to have inherited the severe dopaminergic neurotoxicity of METH and its parent compound amphetamine. Such neurotoxic potential has been found in mice but not in rats (Colado, O’Shea, and Green, 2004), and remains to be established for non-human primates. The probably most prominent publication claiming that MDMA caused irreversible damage to primate DA neurons (Ricaurte et al., 2002) was shown to be in error and had to be retracted. Instead of a recreational dose of MDMA (3 2 mg/kg), the monkeys had, in fact, been given METH, which, at such doses, is known to be neurotoxic in primates (Villemagne et al., 1998). [...]
Table of Contents
1. Introduction
2. Serotonergic changes and neurotoxicity
3. MDMA-induced neuronal oxidative stress
Objectives and Research Themes
The primary aim of this paper is to review and synthesize current empirical findings and theoretical frameworks concerning the molecular and cellular mechanisms of MDMA-induced serotonergic neurotoxicity, while evaluating the evidence regarding potential long-term damage in laboratory animals.
- Mechanisms of MDMA-induced depletion of serotonin (5-HT)
- Distinction between adaptive down-regulation and permanent neurotoxicity
- Role of oxidative stress and reactive oxygen species (ROS) in neural damage
- Evaluation of the "integrated hypothesis" regarding dopamine and serotonin interaction
- Critique of evidence concerning dopaminergic neurotoxicity in primates
Excerpt from the Book
MDMA-induced neuronal oxidative stress
Although MDMA has repeatedly been shown to induce persistent serotonergic changes interpreted as selective neurotoxicity, the molecular and cellular mechanisms underlying its toxic effects are not fully understood. Sprague et al. (1998) proposed an “integrated hypothesis for the serotonergic axonal loss”, which states that MDMA itself is not neurotoxic and that the associated neural damage is actually caused by metabolites of MDMA and DA. Other (complementary) explanations involve neuronal energy exhaustion (Huether, Zhou, and Rüther, 1997), hyperthermia, 5-HT metabolites or excess of intraneuronal calcium, nitric oxide or glutamate (Lyles & Cadet, 2003). For reasons of brevity and clarity, this section will focus on the role of MDMA and DA metabolism in intracellular oxidative stress as mediator of MDMA-induced neurotoxicity.
Oxidative stress is caused by increased formation of reactive oxygen species (ROS), such as free radicals and peroxides, which are byproducts of oxygen (O2) metabolism. ROS ions and molecules can damage proteins, lipids and the DNA of organic cells but are usually readily detoxified by intra- and extracellular enzymes as well as antioxidant molecules (e.g. Vitamin C). However, sufficient concentrations of ROS can overwhelm the protective capabilities of the body’s ROS scavenging system. It has been demonstrated that MDMA regimens with neurotoxic effects increase the amount of extracellular ROS, namely hydroxyl radicals, in the striatum (Shankaran, Yamamoto, and Gudelsky, 1999) and hippocampus (Colado et al., 1999). Their formation may result, for instance, from metabolism of 3,4-dihydroxymethamphetamine (HHMA), the major metabolite of MDMA (Hiramatsu et al., 1990). They react with any oxidizable compound in their proximity, and can induce a chain reaction of lipid and protein destruction, “analogous to a ‘spark’ that starts a fire” (McKersie, 1996).
Chapter Summaries
1. Introduction: This chapter provides an overview of the pharmacology of MDMA, its relationship to methamphetamine and mescaline, and introduces the central debate regarding its selective serotonergic neurotoxicity.
2. Serotonergic changes and neurotoxicity: This section discusses the long-term effects of MDMA on serotonin markers, distinguishing between functional adaptive responses and permanent structural axonal loss.
3. MDMA-induced neuronal oxidative stress: This chapter examines the cellular mechanisms of toxicity, focusing on the roles of oxidative stress, reactive oxygen species, and the interaction between dopamine and serotonin metabolism.
Keywords
MDMA, Ecstasy, neurotoxicity, serotonin, 5-HT, dopamine, oxidative stress, reactive oxygen species, hydroxyl radicals, serotonin transporter, SERT, axonal damage, monoamine oxidase B, neuropharmacology, methamphetamine
Frequently Asked Questions
What is the central focus of this research paper?
The paper focuses on understanding the molecular and cellular mechanisms that drive MDMA-induced neurotoxicity, specifically exploring why the drug appears to selectively affect serotonergic neurons.
What are the primary themes discussed in the text?
The main themes include the pharmacology of MDMA, the long-term impact on brain serotonin levels, the role of oxidative stress, and the controversy regarding whether MDMA causes permanent neuronal damage or temporary adaptive changes.
What is the core research question addressed by the author?
The paper seeks to synthesize empirical evidence to determine how MDMA causes damage to serotonin systems and whether current models, such as the "integrated hypothesis," sufficiently explain this toxicity.
Which scientific methods are primarily utilized in the studies reviewed?
The research reviews a variety of methods, including immunohistochemistry to observe axonal terminal changes, radioligand binding studies, and the measurement of monoamine levels following controlled administration of MDMA and its metabolites in laboratory animals.
What content is covered in the main body of the work?
The main body investigates the biphasic effects of MDMA on serotonin function, the histological evidence for axonal loss, and the biochemical pathways through which reactive oxygen species contribute to neuronal oxidative stress.
Which keywords best characterize this publication?
Key terms include MDMA, serotonergic neurotoxicity, 5-HT, oxidative stress, reactive oxygen species, dopamine, and the serotonin transporter (SERT).
How does MDMA affect the serotonin transporter (SERT)?
MDMA has a high affinity for SERT; it enters the neuron, inhibits the vesicular monoamine transporter (VMAT2), and causes a reversal of the SERT reuptake function, leading to a massive non-exocytotic efflux of serotonin.
Is the observed neurotoxicity necessarily permanent?
There is an ongoing debate; some evidence suggests that observed changes may represent "metabolic quiescence" or adaptive plasticity rather than irreversible structural damage, though many markers show persistent long-term decreases.
Why is dopamine metabolism considered relevant to MDMA toxicity?
The "integrated hypothesis" suggests that dopamine, released under the influence of MDMA, can be metabolized by monoamine oxidase B (MAO-B) into toxic byproducts like hydrogen peroxide, which then contribute to the oxidative stress that damages serotonergic neurons.
- Citation du texte
- Dominik Buchmüller (Auteur), 2009, MDMA-induced serotonergic neurotoxicity, Munich, GRIN Verlag, https://www.grin.com/document/135936
